142 related articles for article (PubMed ID: 37725902)
1. Association of Both Short-term and Long-term Glycemic Variability With the Development of Microalbuminuria in the ACCORD Trial.
Okuno T; Vansomphone A; Zhang E; Zhou H; Koska J; Reaven P; Zhou JJ
Diabetes; 2023 Dec; 72(12):1864-1869. PubMed ID: 37725902
[TBL] [Abstract][Full Text] [Related]
2. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.
Zhou JJ; Koska J; Bahn G; Reaven P
J Clin Endocrinol Metab; 2021 Mar; 106(4):1150-1162. PubMed ID: 33367811
[TBL] [Abstract][Full Text] [Related]
5. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
[TBL] [Abstract][Full Text] [Related]
8. Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.
Long C; Tang Y; Huang J; Liu S; Xing Z
Front Endocrinol (Lausanne); 2022; 13():975468. PubMed ID: 36034445
[TBL] [Abstract][Full Text] [Related]
9. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
[TBL] [Abstract][Full Text] [Related]
10. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
[TBL] [Abstract][Full Text] [Related]
11. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
[TBL] [Abstract][Full Text] [Related]
12. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.
Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC
Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828
[TBL] [Abstract][Full Text] [Related]
14. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
[TBL] [Abstract][Full Text] [Related]
15. HbA1C Variability Is Strongly Associated with Development of Macroalbuminuria in Normal or Microalbuminuria in Patients with Type 2 Diabetes Mellitus: A Six-Year Follow-Up Study.
Chiu WC; Lai YR; Cheng BC; Huang CC; Chen JF; Lu CH
Biomed Res Int; 2020; 2020():7462158. PubMed ID: 32047814
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis.
Wang T; Zhang X; Liu J
Horm Metab Res; 2022 Feb; 54(2):84-93. PubMed ID: 35130569
[TBL] [Abstract][Full Text] [Related]
18. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events.
Sheng L; Yang G; Chai X; Zhou Y; Sun X; Xing Z
Front Endocrinol (Lausanne); 2024; 15():1323571. PubMed ID: 38419951
[TBL] [Abstract][Full Text] [Related]
19. Long-term Visit-to-Visit Variability in Hemoglobin A
Xu Y; Dong S; Fu EL; Sjölander A; Grams ME; Selvin E; Carrero JJ
Am J Kidney Dis; 2023 Sep; 82(3):267-278. PubMed ID: 37182597
[TBL] [Abstract][Full Text] [Related]
20. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study.
Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC
Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
